nifedipine has been researched along with lidoflazine in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (80.95) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 1 (4.76) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barrett, RJ; Johnson, CP; Proakis, AG; Shanklin, JR | 1 |
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Sen, S; Sinha, N | 1 |
| Kapitola, J; Petrásek, J; Vilimovská, D | 1 |
| Fabrègues, E; John, GW; Kamal, M; Massingham, R | 1 |
| Beckeringh, JJ; Hugtenburg, JG; Mathy, MJ; van Zwieten, PA | 1 |
| Beckeringh, JJ; Boddeke, HW; Hugtenburg, JG; Mathy, MJ; van Zwieten, PA | 1 |
| Baky, S; Nademanee, K; Singh, BN | 1 |
| Gudenzi, M; Mustafa, SJ; Nakagawa, Y | 1 |
| Askar, AO; Mustafa, SJ | 1 |
| Borgers, M; Donck, LV; Pauwels, PJ; Vandeplassche, G | 1 |
| Briscoe, MG; Smith, HJ | 1 |
| Barry, WH; Horowitz, JD; Smith, TW | 1 |
| Fossati, C; Guistiniani, S | 1 |
| Lewis, JG | 1 |
| Feely, J; Maclean, D | 1 |
| Dorsey, LM; Guyton, RA; Hatcher, CR; Kates, RA | 1 |
| Colgan, TK; Dorsey, LM; Guyton, RA; Hatcher, CR | 1 |
| McIntyre, KM; Parisi, AF; Sasahara, AA; Strauss, WE | 1 |
| Van Nueten, JM; Vanhoutte, PM | 1 |
| Flaim, SF; Zelis, R | 1 |
3 review(s) available for nifedipine and lidoflazine
| Article | Year |
|---|---|
Second-generation calcium antagonists: search for greater selectivity and versatility.
Topics: Animals; Bepridil; Calcium Channel Blockers; Cinnarizine; Electrophysiology; Flunarizine; Heart; Humans; Lidoflazine; Muscle, Smooth, Vascular; Nicardipine; Nicotinic Acids; Nifedipine; Nimodipine; Nitrendipine; Pyrrolidines; Structure-Activity Relationship | 1985 |
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendiline; Gastrointestinal Diseases; Humans; Lidoflazine; Nervous System Diseases; Nifedipine; Perhexiline; Prenylamine; Verapamil | 1984 |
Adverse reactions to calcium antagonists.
Topics: Calcium Channel Blockers; Diltiazem; Drug Interactions; Humans; Kinetics; Lidoflazine; Nifedipine; Perhexiline; Prenylamine; Risk; Verapamil | 1983 |
1 trial(s) available for nifedipine and lidoflazine
| Article | Year |
|---|---|
Considerations in evaluating new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Drug Evaluation; Humans; Lidoflazine; Nifedipine; Research Design; Verapamil | 1982 |
17 other study(ies) available for nifedipine and lidoflazine
| Article | Year |
|---|---|
Synthesis, calcium-channel-blocking activity, and antihypertensive activity of 4-(diarylmethyl)-1-[3-(aryloxy)propyl]piperidines and structurally related compounds.
Topics: Animals; Antihypertensive Agents; Aorta; Calcium; Calcium Channel Blockers; Hypertension; Male; Molecular Structure; Muscle Contraction; Piperidines; Rabbits; Rats; Rats, Inbred SHR; Structure-Activity Relationship | 1991 |
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
[Effect of lidoflazine, trapymin, and nifedipine on miocardial and other rat tissue blood flow (author's transl)].
Topics: Animals; Blood Circulation; Coronary Circulation; Heart; Lidoflazine; Nifedipine; Piperazines; Pyridines; Pyrimidines; Rats; Trapidil | 1977 |
Caffeine-induced contractions in rabbit isolated renal artery are differentially inhibited by calcium antagonists.
Topics: Animals; Bepridil; Caffeine; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Flunarizine; Kinetics; Lidoflazine; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Renal Artery; Verapamil | 1991 |
The differential effect of calcium antagonists on the positive inotropic effects induced by calcium and monensin in cardiac preparations of rats and guinea-pigs.
Topics: Animals; Bepridil; Calcium; Calcium Channel Blockers; Diltiazem; Gallic Acid; Heart Ventricles; Lidoflazine; Male; Monensin; Myocardial Contraction; Nifedipine; Papillary Muscles; Rats; Rats, Inbred Strains; Ryanodine; Stimulation, Chemical; Verapamil | 1989 |
Differences between negative inotropic and vasodilator effects of calcium antagonists acting on extra- and intracellular calcium movements in rat and guinea-pig cardiac preparations.
Topics: Animals; Calcium; Calcium Channel Blockers; Coronary Circulation; Depression, Chemical; Heart Ventricles; Lidoflazine; Male; Myocardial Contraction; Nifedipine; Papillary Muscles; Rats; Rats, Inbred Strains; Ryanodine; Vasodilator Agents | 1989 |
Calcium entry blocking activity of adenosine potentiating compounds in guinea pig taenia coli.
Topics: Adenosine; Animals; Calcium Channel Blockers; Colon; Dilazep; Diltiazem; Dipyridamole; Drug Synergism; Guinea Pigs; In Vitro Techniques; Lidoflazine; Male; Muscle, Smooth; Nifedipine; Potassium; Vasodilator Agents; Verapamil | 1986 |
Effect of calcium entry blockers and adenosine on the relaxation of large and small coronary arteries.
Topics: Adenosine; Animals; Arteries; Calcium Channel Blockers; Cattle; Coronary Vessels; Dose-Response Relationship, Drug; Gallopamil; Lidoflazine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nifedipine; Theophylline | 1986 |
Isolated rat cardiac myocytes as an experimental model to study calcium overload: the effect of calcium-entry blockers.
Topics: Animals; Calcium; Calcium Channel Blockers; Cinnarizine; Diltiazem; Flunarizine; Heart; Lidoflazine; Male; Myocardial Contraction; Myocardium; Nicardipine; Nifedipine; Rats; Rats, Inbred Strains; Time Factors; Verapamil; Veratrine | 1986 |
The relative sensitization by acidosis of five calcium blockers in cat papillary muscles.
Topics: Acidosis; Animals; Calcium Channel Blockers; Cats; Diltiazem; In Vitro Techniques; Lidoflazine; Myocardial Contraction; Nifedipine; Papillary Muscles; Perhexiline; Verapamil | 1985 |
Comparison of negative inotropic potency, reversibility, and effects on calcium influx of six calcium channel antagonists in cultured myocardial cells.
Topics: Animals; Calcium; Calcium Channel Blockers; Cells, Cultured; Chick Embryo; Gallopamil; Half-Life; Lidoflazine; Myocardial Contraction; Myocardium; Nifedipine; Perhexiline; Time Factors; Verapamil | 1985 |
Calcium antagonists, nitrates, and new antianginal drugs.
Topics: Angina Pectoris; Calcium Channel Blockers; Humans; Hypertension; Isosorbide Dinitrate; Lidoflazine; Nifedipine; Nitrates; Nitroglycerin; Perhexiline; Prenylamine; Tachycardia; Verapamil | 1983 |
Enhancement of cardioplegic myocardial protection with calcium entry blockers.
Topics: Calcium Channel Blockers; Diltiazem; Heart Arrest, Induced; Humans; Lidoflazine; Myocardium; Nifedipine; Organ Preservation; Verapamil | 1984 |
Calcium-channel blockade as an adjunct to heterogeneous delivery of cardioplegia.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Cardiac Output; Dogs; Heart; Heart Arrest, Induced; Heart Rate; Lidoflazine; Nifedipine; Piperazines; Pyridines; Stroke Volume | 1983 |
Calcium entry blockers and vascular smooth muscle heterogeneity.
Topics: Animals; Calcium; Calcium Channel Blockers; Cinnarizine; Flunarizine; Gallopamil; Lidoflazine; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Rabbits; Verapamil | 1981 |
Clinical use of calcium entry blockers.
Topics: Angina Pectoris; Calcium Channel Blockers; Cinnarizine; Coronary Circulation; Coronary Vasospasm; Diltiazem; Flunarizine; Heart Rate; Humans; Lidoflazine; Nifedipine; Perhexiline; Verapamil | 1981 |